ATE82501T1 - Pharmazeutische mittel zur weiblichen sterilisation auf intrauterinem weg und ihre therapeutische anwendung. - Google Patents

Pharmazeutische mittel zur weiblichen sterilisation auf intrauterinem weg und ihre therapeutische anwendung.

Info

Publication number
ATE82501T1
ATE82501T1 AT89403650T AT89403650T ATE82501T1 AT E82501 T1 ATE82501 T1 AT E82501T1 AT 89403650 T AT89403650 T AT 89403650T AT 89403650 T AT89403650 T AT 89403650T AT E82501 T1 ATE82501 T1 AT E82501T1
Authority
AT
Austria
Prior art keywords
intrauterine
way
therapeutic application
pharmaceutical means
female sterilization
Prior art date
Application number
AT89403650T
Other languages
English (en)
Inventor
Jaime Zipper
Original Assignee
Jaime Zipper
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jaime Zipper filed Critical Jaime Zipper
Application granted granted Critical
Publication of ATE82501T1 publication Critical patent/ATE82501T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89403650T 1989-01-31 1989-12-26 Pharmazeutische mittel zur weiblichen sterilisation auf intrauterinem weg und ihre therapeutische anwendung. ATE82501T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8901205A FR2642306A1 (fr) 1989-01-31 1989-01-31 Nouveaux agents pharmacologiques pour la sterilisation feminine par voie intra-uterine et leur emploi therapeutique
EP89403650A EP0380897B1 (de) 1989-01-31 1989-12-26 Pharmazeutische Mittel zur weiblichen Sterilisation auf intrauterinem Weg und ihre therapeutische Anwendung

Publications (1)

Publication Number Publication Date
ATE82501T1 true ATE82501T1 (de) 1992-12-15

Family

ID=9378309

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89403650T ATE82501T1 (de) 1989-01-31 1989-12-26 Pharmazeutische mittel zur weiblichen sterilisation auf intrauterinem weg und ihre therapeutische anwendung.

Country Status (7)

Country Link
EP (1) EP0380897B1 (de)
JP (1) JPH0764730B2 (de)
AT (1) ATE82501T1 (de)
DE (1) DE68903561T2 (de)
ES (1) ES2045517T3 (de)
FR (1) FR2642306A1 (de)
GR (1) GR3007122T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011052A (en) * 1996-04-30 2000-01-04 Warner-Lambert Company Pyrazolone derivatives as MCP-1 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338493A (en) * 1970-11-12 1973-11-21 Biolog Concepts Inc Method of inhibiting the fertility of the reproductive organs of mammals
BE788505A (fr) * 1972-09-05 1973-03-07 Moyer Dean L Dispositif et procede pour l'utilisation d'un medicament irritant-toxique, antipaludeen ou antiamibien
GB1554783A (en) * 1976-01-05 1979-10-31 Population Res Inc Pharmaceutical compositions for use in the permanent sterilization of female animals
US4158050A (en) * 1978-06-15 1979-06-12 International Fertility Research Programme Method for effecting female sterilization without surgery
JPS62501630A (ja) * 1984-12-26 1987-07-02 サンシヤイン，エイブラハム 鎮痛、抗炎症および骨格筋弛緩薬組成物
US4614617A (en) * 1985-02-25 1986-09-30 G. D. Searle & Co. Intermediates for 8-chlorodibenz[(b,f)][1,4]oxazepine-10(11H)-carboxylic acid, 2-(sulfinyl- and sulfonyl-containing acyl)hydrazides

Also Published As

Publication number Publication date
ES2045517T3 (es) 1994-01-16
EP0380897B1 (de) 1992-11-19
EP0380897A1 (de) 1990-08-08
JPH0764730B2 (ja) 1995-07-12
DE68903561T2 (de) 1993-06-17
JPH02215720A (ja) 1990-08-28
FR2642306A1 (fr) 1990-08-03
DE68903561D1 (de) 1992-12-24
GR3007122T3 (de) 1993-07-30

Similar Documents

Publication Publication Date Title
CA2111836A1 (en) Spin-trapping pharmaceutical compositions and methods for use thereof
ES2330516T3 (es) Composicion para el tratamiento de la ictiosis que utiliza la antitripsina.
BR9807892A (pt) Prevenção antimicrobiana e tratamento do vìrus da imunodeficiência humana e outras doenças infecciosas.
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
DE3778781D1 (de) Antiphlogistika enthaltende pharmazeutische formulierungen mit gesteuerter freigabe.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
GR3022742T3 (en) New derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
DE69719189D1 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
DE69322251D1 (de) Medizinische zusammensetzung
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
ES2139842T3 (es) Uso de la melatonina para tratar a pacientes que sufren drogodependencia.
EP0848948A4 (de) Lang wirksames mittel zur rektalen verabreichung
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
ATE82501T1 (de) Pharmazeutische mittel zur weiblichen sterilisation auf intrauterinem weg und ihre therapeutische anwendung.
AU3401093A (en) Therapeutic agent for threatened abortion
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
CA2003981A1 (en) Pharmaceutical compositions and use thereof in the treatment of psoriasis
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO810761L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dibenzo-cyklohepten-derivater
EP0811385A3 (de) Konjugate von einem Interleukin-2 Rezeptor spezifisch erkennenden Faktor mit Ribonuklease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee